Pharma Applications of Dendrimer Technology

The polyvalent nature of dendrimers is increasingly being recognised as a means of overcoming intrinsically weak monovalent interactions, and of generating drugs with totally new activities, modes of action and pharmacokinetic profiles.

Dr Tom McCarthy and Dr Guy Krippner at Starpharma Pty Limited (May 2005)

Keywords: Pharma Applications Dendrimer Technology monovalent pharmacokinetic

View full article    |    Back to Biopharma section